American Capital Advisory’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$742 Hold
2
– – ﹤0.01% 852
2026
Q2
$718 Hold
2
– – ﹤0.01% 876
2026
Q1
$502 Hold
2
– – ﹤0.01% 859
2025
Q4
$551 Buy
2
+1
+100% +$274 ﹤0.01% 731
2025
Q3
$263 Hold
1
– – ﹤0.01% 829
2025
Q2
$219 Buy
+1
New +$214 ﹤0.01% 789

Other funds holding WST

American Capital Advisory's WST Position: Q3 2026 in Review

American Capital Advisory held its West Pharmaceutical (WST) position steady in Q3 2026 at 2 shares worth $742. The position accounts for ﹤0.01% of the portfolio, ranked #852.

American Capital Advisory first reported a position in WST in Q2 2025 and has held it in 6 quarters since. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • American Capital Advisory held 2 shares of West Pharmaceutical worth $742 as of Q3 2026.
  • American Capital Advisory left its West Pharmaceutical share count unchanged in Q3 2026.
  • West Pharmaceutical made up ﹤0.01% of American Capital Advisory's portfolio in Q3 2026, its #852 holding.
  • American Capital Advisory first reported a position in West Pharmaceutical in Q2 2025 and has held it in 6 quarters since.
  • 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on American Capital Advisory's 13F filing for Q3 2026, filed 28 Oct 2026.